Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...

Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.

Convincing healthcare providers and patients of Neffy’s reliability during allergic reactions will require extensive ...

Revenues of Indian pharmaceutical companies are projected to grow by 9-11% in the current financial year, a moderation from ...

Kezar Life Sciences said it voluntarily suspended enrollment and dosing in a clinical trial of a treatment for an autoimmune kidney disease after four patients died.

SIFI, a leading international ophthalmic company, announced that is has received a Notice of Allowance from the European Patent Office ...

BridgeBio Pharma shared new data showing that acoramidis reduced mortality and cardiovascular hospitalizations by 42% in its Phase 3 ATTRibute-CM study for ATTR-CM. FDA decision expected in November ...

Psilocybin, a psychedelic compound, offers promising relief for depression, improving symptoms and social functioning beyond ...

Poland is set to receive shipments of COVID-19 vaccines from Latvia in early October, the Polish health minister announced, ...

US stocks notched up their longest run of quarterly gains since 2021, as Wall Street’s main indices ended the day and the month of September higher.